Your browser doesn't support javascript.
loading
PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity.
Kim, Hyungsoo; Kim, Heejung; Feng, Yongmei; Li, Yan; Tamiya, Hironari; Tocci, Stefania; Ronai, Ze'ev A.
Afiliação
  • Kim H; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 90237, USA. zeev@ronailab.net hkim@sbpdiscovery.org.
  • Kim H; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 90237, USA.
  • Feng Y; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 90237, USA.
  • Li Y; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 90237, USA.
  • Tamiya H; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 90237, USA.
  • Tocci S; Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 90237, USA.
  • Ronai ZA; Technion Integrated Cancer Center, Technion, Haifa 3109601, Israel.
Sci Transl Med ; 12(551)2020 07 08.
Article em En | MEDLINE | ID: mdl-32641491
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Melanoma / Nucleotidiltransferases Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Melanoma / Nucleotidiltransferases Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article